Omics and Drug Response

Annual Review of Pharmacology and Toxicology

Vol. 53:475-502 (Volume publication date January 2013)
First published online as a Review in Advance on November 5, 2012
https://doi.org/10.1146/annurev-pharmtox-010510-100502

Abstract

A new generation of technologies commonly named omics permits assessment of the entirety of the components of biological systems and produces an explosion of data and a major shift in our concepts of disease. These technologies will likely shape the future of health care. One aspect of these advances is that the data generated document the uniqueness of each human being in regard to disease risk and treatment response. These developments have reemphasized the concept of personalized medicine. Here we review the impact of omics technologies on one key aspect of personalized medicine: the individual drug response. We describe how knowledge of different omics may affect treatment decisions, namely drug choice and drug dose, and how it can be used to improve clinical outcomes.

Keywords